Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
69 studies found for:    "Hereditary angioedema"
Show Display Options
RSS Create an RSS feed from your search for:
"Hereditary angioedema"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
Condition: Hereditary Angioedema
Intervention: Drug: C1 esterase inhibitor [human] (C1INH-nf)
2 Completed
Has Results
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Biological: C1 esterase inhibitor [human] (C1INH-nf)
3 Completed
Has Results
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
Condition: Hereditary Angioedema
Intervention: Biological: C1 esterase inhibitor [human] (C1INH-nf)
4 Completed A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Interventions: Biological: Low-volume C1-esterase inhibitor;   Biological: Higher-volume C1-esterase inhibitor;   Biological: Low-volume placebo;   Biological: Higher-volume placebo
5 Recruiting Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
Condition: Hereditary Angioedema
Intervention: Drug: rhC1INH
6 Completed
Has Results
Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Intervention: Drug: ecallantide
7 Completed
Has Results
A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
8 Completed
Has Results
Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant;   Drug: Tranexamic Acid;   Drug: Oral Placebo;   Drug: S.C. Placebo
9 Withdrawn Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema
Condition: Hereditary Angioedema
Intervention: Biological: ecallantide
10 Completed
Has Results
CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
Condition: Hereditary Angioedema
Intervention: Biological: CINRYZE
11 Completed
Has Results
Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema (HAE) Subjects
Condition: Hereditary Angioedema
Interventions: Drug: DX-2930;   Drug: Placebo
12 Unknown  Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Intervention: Drug: Ecallantide subcutaneous dosing
13 Completed
Has Results
Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema
Interventions: Drug: ecallantide;   Drug: Phosphate Buffer Saline (PBS), pH 7.0
14 Active, not recruiting A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Intervention: Drug: icatibant
15 Completed A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Intervention:
16 Completed
Has Results
Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema (HAE)
Interventions: Drug: ecallantide;   Drug: Phosphate Buffer Saline (PBS),
17 Recruiting Efficacy and Safety of BCX7353 to Prevent Angioedema Attacks in Subjects With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Interventions: Drug: BCX7353;   Drug: Placebo
18 Active, not recruiting Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary Angioedema
Condition: Hereditary Angioedema (HAE)
Interventions: Biological: CINRYZE 500;   Biological: CINRYZE 1000
19 Recruiting Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)
Condition: Hereditary Angioedema (HAE)
Interventions: Drug: CINRYZE 500 U;   Drug: CINRYZE 1000 U
20 Active, not recruiting A Study to Evaluate the Long-term Clinical Safety and Efficacy of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Intervention: Biological: C1-esterase inhibitor

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.